Navigation Links
TOPICA Elects G. Kirk Raab as Chairman of the Board
Date:7/16/2009

PALO ALTO, Calif., July 16 /PRNewswire/ -- TOPICA Pharmaceuticals today announced that G. Kirk Raab has been elected chairman of the company's Board of Directors.

"As a pre-eminent leader in the biotechnology industry, and as the former chairman of Connetics Corporation and Oclassen Pharmaceuticals, Kirk Raab brings a proven track record of leadership and success to TOPICA, as well as an exceptional knowledge of the dermatology market," said Greg Vontz, president and chief executive officer of TOPICA. "His addition to our Board builds on our team's extensive experience developing and commercializing significant dermatologic products, and we look forward to working with him."

"Greg and I worked together successfully at Genentech and Connetics Corporation, and I look forward to achieving a similar outcome for TOPICA," said Mr. Raab. "The company is poised for success with its experienced board, management team, significant market potential and novel molecule, luliconazole."

Mr. Raab has more than 45 years of pharmaceutical and biotech experience. For the past 14 years, he has been involved in the management and operations of more than 15 biotech companies, for many of which he served as chairman. He served as chairman of Connetics Corporation, a highly successful dermatology company acquired by Stiefel Laboratories, and most recently was chairman of BiPar Sciences, which was acquired by Sanofi-Aventis. From February 1990 to July 1995, Mr. Raab served as president and chief executive officer of Genentech. He originally joined Genentech in February 1985, as president and chief operating officer. Prior to joining Genentech, Mr. Raab worked for Abbott Laboratories for 10 years, most recently as president, chief operating officer and director. He served as the first chairman of the Biotechnology Industry Organization (BIO) and the California Health Care Institute.

<
'/>"/>

SOURCE TOPICA Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Transdel Pharmaceuticals Completes Enrollment in Phase 3 Clinical Study for Novel Topical Pain Treatment
2. Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis (Pink Eye)
3. Echo Therapeutics Licenses Needle-Free Prelude SkinPrep System to Ferndale Pharma for Enhanced Delivery of Topical Lidocaine
4. Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB)
5. Clinical Topicals Makes Breakthrough Migraine Treatment Available Free to Soldiers
6. U.S. Study Shows Significant Improvement for Patients Suffering from Excessive Sweating with Topical Antiperspirant
7. Topical cream studied as way to treat skin cancer without the knife
8. TOPICA Begins Phase 2 Clinical Trial of Potent Antifungal, Luliconazole, in Athletes Foot
9. Summit VetPharm Offers New Flea Topical Vectra for Dogs & Puppies(TM) For Long-Lasting Protection
10. New Topical Painkiller Relieves Severe Pain in Minutes
11. Topical Dermatological Product Development in the USA Workshop to Be Held on June 4, 2009 in East Brunswick, New Jersey, USA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2015)... Kaylie Corrigan, Outdoor Supervisor at Back2Basics Outdoor ... student obtaining her Masters degree in social work at ... psychoeducation on substance use for teens at the local ... her studies. , “Even though these students are young, ... the high school and junior high school level,” said ...
(Date:2/28/2015)... ON (PRWEB) February 28, 2015 The ... to announce that they have officially relaunched their website. ... more user-friendly, but it contains a new section about ... access to read the full biographies of each Friedman ... portion of the website was designed to provide our ...
(Date:2/28/2015)... 2015 Javon Bea Mercy Health ... Hospital as stroke capable by the State of Illinois, ... to Mercy Harvard Hospital. , The hospital was required ... ability to treat stroke according to national standards of ... stroke patients to bypass hospitals not designated as an ...
(Date:2/28/2015)... Memphis, TN: MedixSafe has retracted a previous ... security reader named Guardian 2. The correct product ... biometric scanner that significantly increases the complexity of ... biometric scanner provides fast and easy access for ... narcotics lockers with Vanguard technology tracks inventory ...
(Date:2/28/2015)... February 28, 2015 1Heart Caregiver ... showcased emerging brand at Houston Texas Franchise Expo ... Vegas sending its executive delegates headed by Vice-President ... Development and Training Randolph Clarito. , Franchise Expo ... held last February 4-7 and featured Franchise brands ...
Breaking Medicine News(10 mins):Health News:Staff at Arizona Drug Addiction Treatment Center Starts Teen Sobriety Support Group at Local High School 2Health News:Friedman Dental Group Announces Their Updated Website 2Health News:Mercy Harvard Hospital Recognized as Leader in Stroke Care - Javon Bea 2Health News:New Name Announced For Newest MedixSafe Readers – MedixSafe Vanguard 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 3
... from your very early childhood i.e. before the age of ... ,Science has always pondered over 'infant amnesia' -inability ... being unable to form memories. , Yet researchers from ... for Advancement of Science, say that on the contrary, babies ...
... to commercial companies over clinical and preclinical trial data—could ... and harm public health, says Karin Timmermans of the ... Medicine. ,Writing in a personal capacity, Ms ... produce generic versions of the "flu drug" oseltamivir in ...
... 26 land beneficiaries in the capital comply with the lease ... a report submitted by the government to the Delhi High ... & Development Organization (L&DO) of the Delhi government had allotted ... out of which only 26 are currently operational. While DDA ...
... Beijing: China is to allow a pioneering doctor, currently under ... States to accept an award for her work on behalf// ... official told me I had permission to travel," retired professor ... where police have been holding her under house arrest for ...
... at the last straw to save their child; using Viagra to ... August when his mother was just into 24 weeks of pregnancy. ... but this was worsened when his lungs collapsed the day after ... had not closed properly. He was operated upon at 3 weeks ...
... promise in slowing progression and prolonging survival time in ... of targeted anti-cancer drugs that blocks the human epidermal ... the lives of patients with recurrent prostate cancer, a ... compound called pertuzumab, works by binding to and inhibiting ...
Cached Medicine News:Health News:Drug Companies Should Not Have a Monopoly Over Clinical Trial Data 2Health News:Private Hospitals Ignore Deal to Provide Free Treatment 2Health News:Viagra Plays Another Role-Premature Baby Saved 2Health News:New Drug Promises Prolonged Survival in Prostate Cancer Patients 2Health News:New Drug Promises Prolonged Survival in Prostate Cancer Patients 3
(Date:2/27/2015)... KING OF PRUSSIA, Pa. , Feb. 27, 2015 ... part of its ongoing commitment to the global bleeding ... it is donating 2 million international units (IUs) of ... WFH is an international not-for- profit organization which has ... and other inherited bleeding disorders. The donation supports the ...
(Date:2/27/2015)... 27, 2015 ... für kongestive Herzinsuffizienz (CHF) in seiner ersten ...     Die israelische ... Herzüberwachungssystem für Patienten mit kongestiver Herzinsuffizienz (CHF) ... ein Finanzierungsvorhaben über 5 Mio. USD abgeschlossen ...
(Date:2/27/2015)... 2015  Two mass spectrometry technologies MALDI ... their effectiveness is established, according to biotechnology ... says that while mass spectrometry (mass spec ... in proteomic biomarker discovery and validation, mass ... techniques has struggled to elucidate molecular distribution ...
Breaking Medicine Technology:CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 2CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 3Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 3
... BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today ... present a company update at the Baird Health Care Conference ... a.m. ET.   Interested parties may access a ... section of the BioMarin website, www.BMRN.com .  A replay ...
... 30, 2011 Perrigo Company (Nasdaq: PRGO ... approval from the U.S. Food and Drug Administration for ... the generic version of Extina® Ketoconazole Foam, 2%. Perrigo ... to file, enabling 180 days of marketing exclusivity. This ...
Cached Medicine Technology:BioMarin to Present at the Baird Health Care Conference 2Perrigo Announces FDA Final Approval for Ketoconazole Foam, 2% 2
0.3 mm hook angled 45 degrees, 9 mm from tip to bend. Flat smooth handle with polished finish. Overall length: 4.6 inches....
2.0 mm cup. Angled 45 degree shaft 8 mm from tip to bend with flat handle and polished finish. Overall length: 4.8 inches....
Round, knurled handle with polished finish and straight shaft. 1 mm ring curette 1.5 mm high, 33 mm shaft. Overall length: 5.1 inches....
0.5 mm curette cup, reverse side of sandblasted to polish capsule. Round knurled handle with polished finish. Overall length: 5 inches....
Medicine Products: